천식 의심 환자에서 천식 치료에 의한 유도 객담 내 염증지표의 변화
Change of Inflammatory Markers in Induced Sputum in Suspected Asthmatics by Asthma Treatment
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Eosinophilic airway inflammation is characteristic for typical asthma, but neutrophilic inflammation has been found in severe asthmatics resistant to steroid therapy. This study aimed to evaluate responses to asthma treatment according to inflammatory cell types in sputum. Methods: For a cross-sectional study, 240 consecutive patients with suspected asthma who underwent a 4.5%saline-induced sputum test and a test for airway hyperresponsiveness to methacholine or for airway reversibility were enrolled. Of these patients, 23 who inhaled corticosteroids were entered to a follow-up sputum study. Results: The number of sputum eosinophils was significantly related to the forced expiratory volume in one second/forced vital capacity (r=−0.180, P<0.05) and airway hyperresponsiveness (r=−0.222, P<0.01), and the number of neutrophils was significantly related to age (r=0.165, P<0.05)and forced expiratory volume in one second (r=−0.157, P<0.05). Subjects with sputum eosinophilia (n=88, 20.5%) had received asthma treatment before the tests more often than those with neutrophilia (n=23, 4.3%) or mixed granulocytic nature (n=11, 0%) (P<0.05 for each). In the follow-up study, the number of eosinophils was significantly decreased in the eosinophilic subjects (P<0.05), and the Δinterferon-γ/interleukin-5 ratio was significantly related to Δeosinophils (r=0.933, P<0.001). There was an inverse relationship between the number of neutrophils and the increase in forced expiratory volume in one second (r=−0.459, P<0.05)or Δinterferon-γ (r=−0.842, P<0.01). Conclusion: The severity of asthma may depend on inflammatory cell types in sputum. Although inflammatory markers of sputum improve by asthma treatment, treatment responses differ according to cell types. Therefore, sputum examination may be useful for predicting therapeutic responses in asthmatics.
Abstract
Background: Eosinophilic airway inflammation is characteristic for typical asthma, but neutrophilic inflammation has been found in severe asthmatics resistant to steroid therapy. This study aimed to evaluate responses to asthma treatment according to inflammatory cell types in sputum. Methods: For a cross-sectional study, 240 consecutive patients with suspected asthma who underwent a 4.5%saline-induced sputum test and a test for airway hyperresponsiveness to methacholine or for airway reversibility were enrolled. Of these patients, 23 who inhaled corticosteroids were entered to a follow-up sputum study. Results: The number of sputum eosinophils was significantly related to the forced expiratory volume in one second/forced vital capacity (r=−0.180, P<0.05) and airway hyperresponsiveness (r=−0.222, P<0.01), and the number of neutrophils was significantly related to age (r=0.165, P<0.05)and forced expiratory volume in one second (r=−0.157, P<0.05). Subjects with sputum eosinophilia (n=88, 20.5%) had received asthma treatment before the tests more often than those with neutrophilia (n=23, 4.3%) or mixed granulocytic nature (n=11, 0%) (P<0.05 for each). In the follow-up study, the number of eosinophils was significantly decreased in the eosinophilic subjects (P<0.05), and the Δinterferon-γ/interleukin-5 ratio was significantly related to Δeosinophils (r=0.933, P<0.001). There was an inverse relationship between the number of neutrophils and the increase in forced expiratory volume in one second (r=−0.459, P<0.05)or Δinterferon-γ (r=−0.842, P<0.01). Conclusion: The severity of asthma may depend on inflammatory cell types in sputum. Although inflammatory markers of sputum improve by asthma treatment, treatment responses differ according to cell types. Therefore, sputum examination may be useful for predicting therapeutic responses in asthmatics.
참고문헌 (40)
- "Global initiative for asthma: Global strategy for asthma management and prevention" (2011)[URL]
- Stone KD, "IgE, mast cells, basophils, and eosinophils", J Allergy Clin Immunol, 125, pp.S73~S80 (2010)
- Commins SP, "Immunologic messenger molecules: cytokines, interferons, and chemokines", J Allergy Clin Immunol, 125, pp.S53~S72 (2010)
- Blanchard C, "Biology of the eosinophil", Adv Immunol, 101, pp.81~121 (2009)
- Jang AS, "Clinical usefulness of induced sputum cell differentials as monitoring indices of asthmatic airway inflammation", Chonnam Med J, 33, pp.201~212 (1997)
- Louis R, "The relationship between airways inflammation and asthma severity", Am J Respir Crit Care Med, 161, pp.9~16 (2000)
- 장안수, "Effects of prednisolone on eosinophils, IL-5, eosinophil cationic protein, EG2+eosinophils, and nitric oxide metabolites in the sputum of patients with exacerbated asthma", JOURNAL OF KOREAN MEDICAL SCIENCE, 15(5), pp.521~528, KOREAN ACAD MEDICAL SCIENCES
- Nair P, "Mepolizumab for prednisone-dependent asthma with sputum eosinophilia", N Engl J Med, 360, pp.985~993 (2009)
- Gibson PG, "Eosinophilic bronchitis : clinical manifestations and implications for treatment", Thorax, 57, pp.178~182 (2002)
- Jatakanon A, "Neutrophilic inflammation in severe persistent asthma", Am J Respir Crit Care Med, 160, pp.1532~1539 (1999)
- Haldar P, "Noneosinophilic asthma: a distinct clinical and pathologic phenotype", J Allergy Clin Immunol, 119, pp.1043~1052 (2007)
- Ownby DR, "Factors underlying the increasing incidence and prevalence of allergic diseases, In Middleton's allergy: principles and practice. 7th ed", pp.769~778 (2009), Mosby Elsevier
- Park SJ, "Interleukin-17 regulation: an attractive therapeutic approach for asthma", Respir Res, 11, pp.78~ (2010)
- Barczyk A, "Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine", Respir Med, 97, pp.726~733 (2003)
- Cockcroft DM, "Measure of airway responsiveness to inhaled histamine or methacholine: method of continuous aerosol generation and tidal breathing inhalation, In Airway responsiveness: measurement and interpretation", pp.22~28 (1985), Astra Pharmaceuticals Canada
- Morris AH, "Clinical pulmonary function testing: a manual of uniform laboratory procedures. 2nd ed" (1984), Intermountain Thoracic Society
- Crapo RO, "Reference spirometric values using techniques and equipment that meet ATS recommendations", Am Rev Respir Dis, 123, pp.659~664 (1981)
- 장안수, "Eosinophil activation markers in induced sputum in asthmatics.", The Korean journal of internal medicine, 15(1), pp.1~7, Korean Association of Internal Medicine[DOI]
- Monteseirín J, "Neutrophils as a novel source of eosinophil cationic protein in IgE-mediated processes", J Immunol, 179, pp.2634~2641 (2007)
- Cowan DC, "Effects of steroid therapy on inflammatory cell subtypes in asthma", Thorax, 65, pp.384~390 (2010)
- Woodruff PG, "Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma", J Allergy Clin Immunol, 108, pp.753~758 (2001)
- Sears MR, "Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children", N Engl J Med, 325, pp.1067~1071 (1991)
- Green RH, "Analysis of inducedsputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids", Thorax, 57, pp.875~879 (2002)
- Lange P, "A 15-year follow-up study of ventilatory function in adults with asthma", N Engl J Med, 339, pp.1194~1200 (1998)
- Hill AT, "Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis", Am J Med, 2000, pp.288~295 (2000)
- Simpson JL, "Inflammatory subtypes in asthma: assessment and identification using induced sputum", Respirology, 11, pp.54~61 (2006)
- Meagher LC, "Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes", J Immunol, 156, pp.4422~4428 (1996)
- Green RH, "Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial", Lancet, 360, pp.1715~1721 (2002)
- Gauvreau GM, "Increased levels of airway neutrophils reduce the inhibitory effects of inhaled glucocorticosteroids on allergen-induced airway eosinophils", Can Respir J, 9, pp.26~32 (2002)
- Fahy JV, "Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies", Proc Am Thorac Soc, 6, pp.256~259 (2009)
- Norzila MZ, "Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma", Am J Respir Crit Care Med, 161, pp.769~774 (2000)
- Yasui K, "Effects of theophylline on human eosinophil functions: comparative study with neutrophil functions", J Leukoc Biol, 68, pp.194~200 (2000)
- Everitt BS, "The Cambridge dictionary of statistics. 3rd ed" (2006), Cambridge University Press
- Pavord ID, "Non-eosinophilic corticosteroid unresponsive asthma", Lancet, 353, pp.2213~2214 (1999)
- Shaw DE, "Association between neutrophilic airway inflammation and airflow limitation in adults with asthma", Chest, 132, pp.1871~1875 (2007)
- Burrows B, "Association of asthma with serum IgE levels and skin-test reactivity to allergens", N Engl J Med, 320, pp.271~277 (1989)
- Milner T, "Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status", Parasite Immunol, 32, pp.710~721 (2010)
- Koh GC, "Eosinophil cationic protein: is it useful in asthma? A systematic review", Respir Med, 101, pp.696~705 (2007)
- McCreanor J, "Respiratory effects of exposure to diesel traffic in persons with asthma", N Engl J Med, 357, pp.2348~2358 (2007)
- Wark PA, "Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma", Eur Respir J, 19, pp.68~75 (2002)
